Natriumklorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumklorid Fresenius Kabi, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume and maintain electrolyte balance in patients with dehydration, hypovolemia, or hyponatremia. It is indicated for fluid and electrolyte replacement in various clinical settings, such as surgery, trauma, and intensive care.

GNH USA supplies Natriumklorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and transplant centres worldwide, ensuring consistent quality and regulatory compliance.

Natriumklorid Fresenius Kabi is used in the electrolyte and fluid replacement pathway to correct volume deficits and sodium imbalances. - Fluid replacement: restores extracellular fluid volume in patients with dehydration or blood loss. - Electrolyte replenishment: provides sodium and chloride ions to correct hyponatremia. - Hypovolemia: increases circulating blood volume in shock or trauma situations. - Hyponatremia: raises serum sodium concentration to safe levels in dilutional states. - Perioperative care: maintains electrolyte balance during surgery.

Intravenous sodium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort or burning at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Hypernatremia: elevated serum sodium if administered excessively. - Fluid overload: mild swelling or weight gain due to excess volume. - Electrolyte imbalance: transient shifts in potassium or calcium levels.

Serious or Rare Side Effects: - Severe hypernatremia: neurological symptoms such as confusion or seizures. - Pulmonary edema: accumulation of fluid in the lungs causing respiratory distress. - Anaphylactic reaction: rare hypersensitivity with hives, airway swelling, or hypotension. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte disturbances. - Metabolic acidosis: rare shift in blood pH from excessive chloride load.

Before using Natriumklorid Fresenius Kabi, clinicians should consider several safety measures to minimize risks. - Assess fluid status: evaluate patient volume and electrolyte levels prior to infusion. - Monitor serum sodium: check sodium concentrations regularly during therapy. - Adjust infusion rate: tailor administration speed to the patient’s cardiac and renal function. - Avoid in severe fluid overload: risk of pulmonary edema in patients with heart failure. - Use aseptic technique: prevent contamination of the injection solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride can interact with other medications, influencing electrolyte balance or fluid status.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause severe hypernatremia. - Loop diuretics: increase risk of electrolyte disturbances when combined. - Corticosteroids: can potentiate sodium retention and fluid overload.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and potassium levels. - NSAIDs: may affect renal sodium handling and increase fluid retention. - Blood transfusion: watch for volume overload when given together.